POOJA MANROA
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SOUTH PASADENA, CA NPI 1831487552
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism CA DEXCOM, INC. All categories
General Payments — all program years on this page
$768.13
- Category: General Payments
- Program years: PY2019–2024
- Record count: 31
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $239.80 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $239.80 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| DEXCOM, INC. | $60.50 | 2 |
| Abbott Laboratories | $53.39 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $33.72 | 1 |
| Averitas Pharma Inc. | $25.90 | 1 |
| Lilly USA, LLC | $25.02 | 1 |
| Corcept Therapeutics | $21.66 | 1 |
| Novo Nordisk AS | $19.61 | 1 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086196462 | Bayer Healthcare Pharmaceuticals Inc. | $33.72 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097509913 | Novo Nordisk Inc | $19.61 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117779887 | Corcept Therapeutics | $21.66 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125295794 | Abbott Laboratories | $25.57 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125295796 | Abbott Laboratories | $27.82 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1133435681 | Averitas Pharma Inc. | $25.90 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135298274 | Lilly USA, LLC | $25.02 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153328323 | Dexcom, Inc. | $31.35 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153328325 | Dexcom, Inc. | $29.15 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.